Morphological characteristics of the cerebral cortex of a mini-pig under conditions of gene therapy after experimental stroke

Aim. To study the effectiveness of preventive gene therapy (within 2 days) and gene therapy in the acute phase (after 4 hours) of ischemic stroke in mini-pigs using an autologous leucoconcentrate (AutoLeuc) enriched with recombinant genes of vascular endothelial growth factor (VEGF165), glial cell line-derived neurotrophic factor (GDNF) and neural cell adhesion molecule 1 (NCAM1), as well as the migration of leukocytes transduced with a chimeric adenoviral vector serotype 5 with fiber 35 serotype (Ad5/F35) and the green fluorescent protein (GFP) genome into immune defense organs.

Materials and methods. The experiment was conducted on 8-month-old Vietnamese lop-bellied mini-pigs (n=16). An ischemic stroke was created by occlusion of the distal branches of the left middle cerebral artery and the right common carotid artery. Genetically modified AutoLeuc was administered preventively intravenously 2 days before or in the acute phase 4 hours after stroke modelling; the control group was injected with 30 ml of saline solution. The morphology of the cerebral cortex was assessed using histological methods in the areas bordering the infarction and peri-infarction after 21 days. The migration of genetically modified Ad5/F35-GFP leukocytes into the brain, spleen, and submandibular lymph nodes was studied a week after stroke modelling.

Results. In the peri-infarction zone, the content of pyknotic neurons in control animals was higher, while the number of capillaries was lower than in the gene therapy groups. In the latter, neurons had a typical morphology with preserved outgrowths; in the control group, the outgrowths were tortuous and fragmented. Fluorescence microscopy after injection of AutoLeuc with Ad5/F35-GFP revealed GFP-positive cells in the spleen and submandibular lymph nodes.

Conclusion. 21 days after modeling a stroke in mini-pigs against the background of preventive gene therapy or gene therapy in the acute phase using VEGF165/GDNF/NCAM1 AutoLeuc, greater preservation of neurons and a higher density of capillaries in the peri-infarction zone of ischemic brain damage were established. Leukocytes with Ad5/ F35-GFP were found in the spleen and submandibular lymph nodes.

1. Saini V., Guada L., Yavagal D.R. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021 Nov 16; 97(20 Suppl 2): S6–S16. https://doi.org/10.1212/WNL.0000000000012781. PMID: 34785599

2. Campbell B.C., De Silva D.A., Macleod M.R., et al. Ischaemic stroke. Nat Rev Dis Prim. 2019 Oct 10; 5(1): 70. https://doi.org/10.1038/s41572-019-0118-8. PMID: 31601801

3. Чикризова Е.А., Коломиец Т.В., Зерчанинова Е.И. Современные методы лечения ишемических инсультов и их осложнения. Тенденции развития науки и образования. 2022; 86(3): 121–125. https://doi.org/10.18411/trnio-06-2022-122

4. Кудрявцева В.А., Кузьмин Е.А., Моисеева А.В. и др. Молекулярные и морфологические маркеры гибели нейронов при острых нарушениях мозгового кровообращения. Сеченовский вестник. 2022; 13(4): 18–32. https://doi.org/10.47093/2218-7332.2022.13.4.18-32

5. Hasan T.F., Hasan H., Kelley R.E. Overview of acute ischemic stroke evaluation and management. Biomedicines. 2021 Oct 16; 9(10): 1486. https://doi.org/10.3390/biomedicines9101486. PMID: 34680603; PMCID: PMC8533104

6. Lavrov I., Islamov R. Implementing principles of neuroontogenesis and neuroplasticity for spinal cord injury therapy. Front Biosci (Landmark Ed). 2022 May 19; 27(5): 163. https://doi.org/10.31083/j.fbl2705163. PMID: 35638430

7. Kuriakose D., Xiao Z. Pathophysiology and treatment of stroke: present status and future perspectives. Int J Mol Sci. 2020 Oct 15; 21(20): 7609. https://doi.org/10.3390/ijms21207609. PMID: 33076218; PMCID: PMC7589849

8. Puhl D.L., D’Amato A.R., Gilbert R.J. Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors. Brain Res Bull. 2019 Aug; 150: 216–230. https://doi.org/10.1016/j.brainresbull.2019.05.024. Epub 2019 Jun 5. PMID: 31173859; PMCID: PMC8284997

9. Craig A.J., Housley G.D. Evaluation of gene therapy as an intervention strategy to treat brain injury from stroke. Front Mol Neurosci. 2016; 9: 34. https://doi.org/10.3389/fnmol.2016.00034. PMID: 27252622; PMCID: PMC4877374

10. Alfonsetti M., d’Angelo M., Castelli V. Neurotrophic factorbased pharmacological approaches in neurological disorders. Neural Regen Res. 2023 Jun; 18(6): 1220–1228. https://doi.org/10.4103/1673-5374.358619. PMID: 36453397; PMCID: PMC9838155

11. Rhim T., Lee M. Targeted delivery of growth factors in ischemic stroke animal models. Expert Opin Drug Deliv. 2016; 13(5): 709– 723. https://doi.org/10.1517/17425247.2016.1144588. Epub 2016 Feb 6. PMID: 26788902

12. Parambi D.G.T., Alharbi K.S., Kumar R., et al. Gene therapy approach with an emphasis on growth factors: theoretical and clinical outcomes in neurodegenerative diseases. Mol Neurobiol. 2022 Jan; 59(1): 191–233. https://doi.org/10.1007/s12035021-02555-y. Epub 2021 Oct 15. PMID: 34655056; PMCID: PMC8518903

13. Gan Y., Jing Z., Stetler R.A., Cao G. Gene delivery with viral vectors for cerebrovascular diseases. Front Biosci (Elite Ed). 2013 Jan 1; 5(1): 188–203. https://doi.org/10.2741/e607. PMID: 23276981; PMCID: PMC5516729

14. Safiullov Z., Izmailov A., Sokolov M., et al. Autologous genetically enriched leucoconcentrate in the preventive and acute phases of stroke treatment in a mini-pig model. Pharmaceutics. 2022 Oct 17; 14(10): 2209. https://doi.org/10.3390/pharmaceutics14102209. PMID: 36297644; PMCID: PMC9611398

15. Melià-Sorolla M., Castaño C., Degregorio-Rocasolano N., et al. Relevance of porcine stroke models to bridge the gap from pre-clinical fi ndings to clinical implementation. Int J Mol Sci. 2020 Sep 8; 21(18): 6568. https://doi.org/10.3390/ijms21186568. PMID: 32911769; PMCID: PMC7555414

16. Bonkhoff A.K., Schirmer M.D., Bretzner M., et al. Outcome after acute ischemic stroke is linked to sex-specifi c lesion patterns. Nat Commun. 2021 Jun 2; 12(1): 3289. https://doi.org/10.1038/s41467-021-23492-3. PMID: 34078897; PMCID: PMC8172535

17. Seregin S.S., Amalfi tano A. Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors. Expert Opin Biol Ther. 2009 Dec; 9(12): 1521–1531. https://doi.org/10.1517/14712590903307388. PMID: 19780714

18. Маркосян В.А., Измайлов А.А., Соколов М.Е. и др. Модель мелкоочагового ишемического инфаркта головного мозга как основа для разработки новых методов терапии инсульта. Казанский Медицинский Журнал. 2023; 104(2): 242– 248. https://doi.org/10.17816/KMJ112404

19. Simoes Braga Boisserand L., Bouchart J., Geraldo L.H., et al. VEGF-C promotes brain-derived fl uid drainage, confers neuroprotection, and improves stroke outcomes. bioRxiv Prepr Serv Biol. [Preprint]. 2023 May 30 https://doi.org/10.1101/2023.05.30.542708. PMID: 37398128; PMCID: PMC10312491.

20. Cintrón-Colón A.F., Almeida-Alves G., Boynton A.M., et al. GDNF synthesis, signaling, and retrograde transport in motor neurons. Cell Tissue Res. 2020 Oct; 382(1): 47–56. https:// doi.org/10.1007/s00441-020-03287-6. Epub 2020 Sep 8. PMID: 32897420; PMCID: PMC7529617

21. Miguel-Hidalgo J.J. Neuroprotective astroglial response to neural damage and its relevance to affective disorders. Explor neuroprotective Ther. 2023; 3(5): 328–345. https://doi.org/10.37349/ent.2023.00054. Epub 2023 Oct 31. PMID: 37920189; PMCID: PMC10622120

22. Сафиуллов З.З., Гаранина Е.Е., Измайлов А.А. и др. Адресная миграция и выживание генетически модифицированных мононуклеарных клеток крови пуповины человека после трансплантации G93A мышам с моделью бокового амиотрофического склероза. Гены и клетки. 2015; 10(4): 86–89. https:// doi.org/10.23868/gc120519

23. Zhao Y., Zhang X., Chen X., Wei Y. Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment (Review). Int J Mol Med. 2022 Feb; 49(2): 15. https://doi.org/10.3892/ijmm.2021.5070. Epub 2021 Dec 8. PMID: 34878154; PMCID: PMC8711586

24. Ekkert A., Šliachtenko A., Grigaitė J., et al. Ischemic stroke genetics: what is new and how to apply it in clinical practice? Genes (Basel). 2021 Dec 24; 13(1): 48. https://doi.org/10.3390/genes13010048. PMID: 35052389; PMCID: PMC8775228

25. Islamov R., Bashirov F., Izmailov A., et al. New therapy for spinal cord injury: autologous genetically-enriched leucoconcentrate integrated with epidural electrical stimulation. Cells. 2022 Jan 2; 11(1): 144. https://doi.org/10.3390/cells11010144. PMID: 35011706; PMCID: PMC8750549